Sanofi US has issued a voluntary recall of all Auvi-Q epinephrine auto-injectors in the US, including both the 0.15mg and 0.3mg doses. They have been found to potentially deliver the wrong dosage.
the firm has received 26 reports of suspected device malfunctions in the US and Canada as of October 26, though none of these malfunctions have been confirmed by the company and no fatalities have been reported to date.
We urge you to read the Sanofi press release and take immediate action to replace all Auvi-Q devices with other alternatives until the firm has resolved the issue.
Sanofi’s Canadian subsidiary issued a recall in June of a number of Allerject auto-injectors due to defects. Allerject is the Canadian version of the Auvi-Q.